Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-9,875
Closed -$519K – 1015
2025
Q4
$519K Sell
9,875
-6,981
-41% -$354K 0.01% 492
2025
Q3
$917K Buy
16,856
+10,704
+174% +$574K 0.02% 357
2025
Q2
$283K Buy
+6,152
New +$283K 0.01% 559

Other funds holding VEON

Caxton Associates (UK)'s VEON Position: Q1 2026 in Review

Caxton Associates (UK) sold out of VEON (VEON) in Q1 2026, closing a stake of 9,875 shares — an estimated $519K sold.

Caxton Associates (UK) first reported a position in VEON in Q2 2025 and held it in 3 quarters. The position peaked at $917K in Q3 2025. 102 funds tracked by Wall St. Rank hold VEON as of Q1 2026.

  • Caxton Associates (UK) reported no remaining VEON position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 9,875 VEON shares in Q1 2026, an estimated $519K.
  • Caxton Associates (UK) first reported a position in VEON in Q2 2025 and held it in 3 quarters.
  • Caxton Associates (UK)'s VEON position peaked at $917K in Q3 2025.
  • 102 funds tracked by Wall St. Rank held VEON as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.